I would have thought they’d follow the results up with an Investor Presentation. Clearly explain what do these results mean for investors. Maybe a bit more time sell the results, and a little less time on issuing shares.
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-115
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $10.07K | 3.191M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 22568002 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 127369917 | 27 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |